epigallocatechin gallate has been researched along with Thyroid Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biray Avci, C; Birden, N; Goker Bagca, B; Gunduz, C; Ozates, NP; Sabour Takanlou, L; Sabour Takanlou, M; Selvi Gunel, N | 1 |
| Allegri, L; Baldan, F; Damante, G; Filetti, S; Mio, C; Rosignolo, F | 1 |
| Andò, S; Aquila, S; Bonofiglio, D; De Amicis, F; Giordano, C; Mauro, L; Panno, ML; Perri, A; Russo, A; Tramontano, D; Vizza, D | 1 |
| Cha, YY; Lim, YC | 1 |
4 other study(ies) available for epigallocatechin gallate and Thyroid Neoplasms
| Article | Year |
|---|---|
The effects of Epigallocatechin-3-gallate and Dabrafenib combination on apoptosis and the genes involved in epigenetic events in anaplastic thyroid cancer cells.
Topics: Apoptosis; Catechin; Cell Line, Tumor; Epigenesis, Genetic; Humans; Imidazoles; Oximes; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms | 2022 |
Effects of nutraceuticals on anaplastic thyroid cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Catechin; Cell Differentiation; Cell Growth Processes; Cell Line, Tumor; Curcumin; Dietary Supplements; Genistein; Humans; MicroRNAs; Resveratrol; Stilbenes; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms | 2018 |
Epigallocatechin gallate inhibits growth and epithelial-to-mesenchymal transition in human thyroid carcinoma cell lines.
Topics: Actins; Apoptosis; Cadherins; Catechin; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Down-Regulation; Epithelial-Mesenchymal Transition; Homeodomain Proteins; Humans; Integrin alpha5; MAP Kinase Signaling System; Matrix Metalloproteinase 9; Nuclear Proteins; Proto-Oncogene Proteins c-akt; Thyroid Neoplasms; Transcription Factors; Tumor Suppressor Protein p53; Twist-Related Protein 1; Up-Regulation; Vimentin; Zinc Finger E-box-Binding Homeobox 1 | 2013 |
Epigallocatechin-3-gallate induces growth inhibition and apoptosis of human anaplastic thyroid carcinoma cells through suppression of EGFR/ERK pathway and cyclin B1/CDK1 complex.
Topics: Anticarcinogenic Agents; Apoptosis; Carcinoma; Catechin; CDC2 Protein Kinase; Cell Line, Tumor; Cell Proliferation; Cyclin B1; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Humans; Signal Transduction; Thyroid Neoplasms | 2011 |